ALTERATIONS IN PLATELET-FUNCTION MONITORED DURING AND AFTER CORONARY REVASCULARIZATION - IMPLICATIONS FOR THE TIMING, EFFICACY AND SAFETY OF ANTIPLATELET THERAPY

被引:0
|
作者
RATNATUNGA, CP
REES, GM
KOVACS, IB
机构
[1] ST BARTHOLOMEWS HOSP,THROMBOSIS UNIT,LONDON EC1A 7BE,ENGLAND
[2] ST BARTHOLOMEWS HOSP,DEPT CARDIOTHORAC SURG,LONDON EC1A 7BE,ENGLAND
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1142 / 1142
页数:1
相关论文
共 50 条
  • [1] Safety and efficacy of platelet inhibition during hybrid coronary revascularization
    Levine, Jason C.
    Feseha, Habteab
    Miller, Kelly L.
    Reyes, Peter A.
    Reicher, Barry
    Poston, Robert S.
    Zimrin, David
    [J]. CHEST, 2007, 132 (04) : 467S - 468S
  • [2] Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
    Karjalainen, Pasi P.
    Porela, Pekka
    Ylitalo, Antti
    Vikman, Saila
    Nyman, Kai
    Vaittinen, Mari-Anne
    Airaksinen, Tuukka J.
    Niemela, Matti
    Vahlberg, Tero
    Airaksinen, K. E. Juhani
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 (06) : 726 - 732
  • [3] Efficacy and safety of antiplatelet therapy including ticlopidine after coronary artery stenting
    Namiki, A
    Ishikawa, M
    Nakamura, M
    Yamaguchi, T
    [J]. ADVANCES IN CORONARY ARTERY DISEASE, 2001, : 611 - 614
  • [4] Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting
    Karjalainen, Pasi
    Ylitalo, Antti
    Porela, Pekka
    Airaksinen, Tuukka
    Vikman, Saila
    Niemela, Matti
    Nyman, Kai
    Vaittinen, Marianne
    Airaksinen, Juhani
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 199M - 199M
  • [5] Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease
    Hwang, Doyeon
    Park, Kyung Woo
    Lee, Joo Myung
    Rhee, Tae-Min
    Hong, Myeong-Ki
    Jang, Yangsoo
    Valgimigli, Marco
    Colombo, Antonio
    Gilard, Martine
    Palmerini, Tullio
    Stone, Gregg W.
    Kim, Hyo-Soo
    [J]. AMERICAN HEART JOURNAL, 2018, 197 : 103 - 112
  • [6] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    [J]. GLOBAL HEART, 2023, 18 (01)
  • [7] PLATELET-FUNCTION AND SURVIVAL CHANGES BEFORE AND AFTER CORONARY-ARTERY REVASCULARIZATION - ASSESSMENT OF THE INFLUENCE OF DIPYRIDAMOLE AND ACETYLSALICYLIC-ACID
    SALTER, MCP
    CROW, MJ
    LEAROYD, P
    RAJAH, SM
    [J]. HAEMOSTASIS, 1982, 12 (1-2) : 191 - 191
  • [8] Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
    Cuisset, Thomas
    Deharo, Pierre
    Quilici, Jacques
    Johnson, Thomas W.
    Deffarges, Stephanie
    Bassez, Clemence
    Bonnet, Guillaume
    Fourcade, Laurent
    Mouret, Jean Philippe
    Lambert, Marc
    Verdier, Valentine
    Morange, Pierre Emmanuel
    Alessi, Marie Christine
    Bonnet, Jean Louis
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (41) : 3070 - 3078
  • [9] Safety and efficacy of prolonged dual antiplatelet therapy following complex percutaneous coronary artery revascularization with drug-eluting stents
    Giustino, G.
    Chieffo, A.
    Palmerini, T.
    Valgimigli, M.
    Feres, F.
    Abizaid, A.
    Hong, M. K.
    Kim, H. S.
    Gilard, M.
    Morice, M. C.
    Leon, M. B.
    Bhatt, D. L.
    Genereux, P.
    Stone, G. W.
    Colombo, A.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 839 - 839
  • [10] Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis
    Zhang Yong
    Tang Hai-qin
    Li Jin
    Fu Zhao-xin
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (09) : 1750 - 1754